FINANCIAL INSTRUMENTS - Narrative (Details)	1 Months Ended	12 Months Ended
	Dec. 31, 2016 USD ($)	Dec. 31, 2019 USD ($) contract	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Sep. 07, 2016 USD ($)	Nov. 30, 2013 USD ($)
Fair Value Measurements Of Financial Instruments [Line Items]
Number of contracts entered into during year | contract		0
Accumulated deferred losses, gross		$ 6,300,000	$ 3,900,000
Accumulated deferred losses		1,221,200,000	1,056,800,000	$ 770,400,000
Derivative financial instruments		$ 0	0
6.25% Senior Notes due 2024
Fair Value Measurements Of Financial Instruments [Line Items]
Stated interest rate (as a percent)		6.25%			6.25%
Foreign exchange contracts
Fair Value Measurements Of Financial Instruments [Line Items]
Term of contract		1 year
Notional amount of derivative		$ 0	0
Interest rate swap
Fair Value Measurements Of Financial Instruments [Line Items]
Term of contract	3 years
Notional amount of derivative	$ 400,000,000					$ 400,000,000
Floor interest rate (percent)	0.75%					1.00%
Fixed interest rate (percent)						2.0709%
Fixed interest rate on debt (percent)						5.5709%
Accumulated deferred losses, gross					$ 6,300,000
Interest rate swap | Deferred gain - hedging
Fair Value Measurements Of Financial Instruments [Line Items]
Accumulated deferred losses			0	$ 700,000	$ 3,900,000
Standby letters of credit which support Products Corporation self insurance programs
Fair Value Measurements Of Financial Instruments [Line Items]
Standby and trade letters of credit for various corporate purposes		8,300,000	7,300,000
Sublimit, letters of credit
Fair Value Measurements Of Financial Instruments [Line Items]
Standby and trade letters of credit for various corporate purposes		$ 11,400,000	$ 10,100,000